Navigation Links
BioWa Announces Licensing of BioWa's POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
Date:10/19/2007

PRINCETON, N.J., Oct. 19 /PRNewswire/ -- BioWa, Inc. (BioWa) announced today that it has entered into a research agreement which provides GlaxoSmithkline (GSK) with access to BioWa's patented POTELLIGENT(R) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.

The agreement grants GSK non-exclusive rights to research and develop antibodies based on POTELLIGENT(R) Technology for an undisclosed number of targets. In return, BioWa will receive an upfront payment, and license fees. Other details of the agreement are not disclosed.

"GSK has long time remained a strong leader in the pharmaceutical industry for both innovation and marketing," said Dr. Masamichi Koike, President and CEO of BioWa. "With the breadth and depth of GSK research, we are pleased to partner with a company that has large capabilities in all sectors of research. This collaboration will fulfill BioWa's mission to create benefit of POTELLIGENT(R) Technology to patients as quickly as possible."

About POTELLIGENT(R) Technology

POTELLIGENT(R) Technology improves potency and efficacy of antibody therapeutics, by enhancing antibody-dependent cellular cytotoxicity (ADCC), one of the major mechanism of antibody therapeutics. POTELLIGENT(R) Technology involves the reduction of the amount of fucose in the carbohydrate structure of an antibody using a proprietary fucosyltransferase-knockout CHO cell line as a production cell. Research shows that POTELLIGENT(R) Technology significantly enhances ADCC activity of an antibody in vitro, thereby increasing the potential for improved activity in vivo.

About BioWa, Inc.

BioWa is a wholly owned subsidiary of Kyowa Hakko Kogyo Co., Ltd., Japan's pharmaceutical and largest biotech company, and is the exclusive worldwide licensor of POTELLIGENT(R) Technology, which creates high ADCC monoclonal antibodies. Currently, BioWa is developing ADCC enhanced monoclonal antibody- base
'/>"/>

SOURCE BioWa, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...ivednoticefrom,theNasdaqStockMarketthattradinginth...0,2009andaForm25-NSEwillbefiledwiththe,Securitiesa...stock,fromlistingonNasdaq,unlessthecompanyfilesana...panyhasfiledsuchanappeal,which,willstaythesuspensi...
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...allofits,"firstday"motionsbytheU.S.BankruptcyCourt...CODElastweekfiledavoluntarypetitionfor,reliefunder...nkruptcyCourt. , TheordersissuedbytheBankrupt...essduringtheChapter11proceedings.Inparticular,the,...
(Date:11/24/2009)...4/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Ch...ovedthe,investigationalnewdrugapplication(IND)fori...ormulationtotreatdiabetes.ThisIND,approvalallowsBi... Diabetesisadisordercharacteristicofhighbloodgluco...enresultinseveremicro-and,macro-vasculardiseases,l...
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...oy, N.Y. Researchers at Rensselaer Polytechnic In...nexpensive, quick-drying polymer that could lead t...miconductor manufacturing and computer chip packag...nd cost savings for conventional photolithography ...siloxane (PES), should also enable a new generatio...
...E, Jan. 28 Cell Therapeutics, Inc.,(CTI) (Nasdaq ...g today,shareholders approved the proxy proposal a...corporation to increase the number of authorized,s...ase the number of,authorized shares of common stoc...co, Chief Financial Officer at CTI, who chaired th...
...ON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaT...d that it has signed a,collaborative research agre...velop a combination therapy for the treatment of l...he Company,s lead oncology product,SL052, with var...that,photodynamic therapy (PDT) can augment the th...
Other Biology Technology:New polymer could improve semiconductor manufacturing, packaging 2Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3
(Date:11/24/2009)...lable in Spanish . , The presence of increa...mmatory substances in the blood, hinders the loss ...arch project of the University of Navarra conducte...School of Pharmacy. , The project, entitled "A n...the control of body weight and inflammation," exam...
(Date:11/23/2009)... community-associated strain of the deadly superbu...ost common antibioticsposes a far greater health t...into hospitals, according to a study in the Decemb...he new threat is easily picked up in fitness cente...ased the overall burden of MRSA within hospitals, ...
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Lower Drinking Age Linked to Later Life Problems 57675 1Lower Drinking Age Linked to Later Life Problems 57675 2Lower Drinking Age Linked to Later Life Problems 57675 3Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 1Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 2
...The Stowers Institutes Trainor Lab has demonstrate...velopment of the nervous system, a process that re... neural cells with the cycle of cell division that...s regulating these distinct cellular activities ha...be published in the Feb. 15 issue of Development. ...
...MADISON, WI, January 28, 2008 -- As organic farmin...n the industry are increasingly important. In a re...ientists successfully use nitrogen isotopic discri...rtilizers were used on sweet pepper plants. , Sci...y Desarrollo Agrario y Agrario y Alimentario (IMID...
... Virginia Key, Fla.-- The University of Miamis Ros...nnounced today that it has selected Dennis J. McGi...enstiel Award. McGillicuddy, a senior scientist in...eering at the Woods Hole Oceanographic Institution...study of physical-biological interactions in the o...
Other Biology News:Trainor Lab characterizes gene essential for prenatal development of nervous system 2Is it organic or not? 2Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award 2
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
27-mer duplex from B-Bridge International
Propidium Iodide Buffer from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: